U.S., July 29 -- ClinicalTrials.gov registry received information related to the study (NCT07088419) titled '"Sexual Health Assessment of TinidaZole Against M. Genitalium (SHAZAM)"' on May 28.
Brief Summary: The objective is to estimate the efficacy of tinidazole for the treatment of Mycoplasma genitalium (MG) among male patients who have been diagnosed with non-gonococcal urethritis (NGU) at the Public Health - Seattle &King County (PHSKC) Sexual Health Clinic (SHC). Tinidazole was approved by the Food and Drug Administration (FDA) in May 2004 to treat other infections (i.e., trichomoniasis, giardiasis, amebiasis, bacterial vaginosis) but has not been systematically tested for effectiveness against M. genitalium. The dosing that we are pr...